Financial Results, Fraud Risk Report, Updated Technology, Private Label Segment Report and Partnerships - Research Report on

   Financial Results, Fraud Risk Report, Updated Technology, Private Label
 Segment Report and Partnerships - Research Report on priceline.com, Alliance
                 Data, Cardtronics, Verisk, and athenahealth

PR Newswire

NEW YORK, November 25, 2013

NEW YORK, November 25, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting
priceline.com Incorporated (NYSE: PCLN), Alliance Data Systems Corporation
(NYSE: ADS), Cardtronics Inc. (NASDAQ: CATM), Verisk Analytics, Inc. (NASDAQ:
VRSK), and athenahealth, Inc. (NASDAQ: ATHN). Today's readers may access these
reports free of charge - including full price targets, industry analysis and
analyst ratings - via the links below.

priceline.com Incorporated Research Report

On November 19, 2013, priceline.com Incorporated (priceline.com) announced a
new beta version of its iPad app that brings travel exploration, research and
booking capabilities together in one interface. According to priceline.com,
its new Explore functionality unhinges travel aspirations and empowers
consumers to discover new popular priceline.com destinations around the world,
while comparing prices, reducing the need to research and book travel at
different times in different places. "Our iPad customers are in the early
stages of travel planning, often booking further in advance for longer lengths
of stay compared to smartphone users. In fact, iPad users are almost three
times more likely to book 10+ days in advance than iPhone users," said John
Caine, Chief Product Officer of priceline.com. "We've designed this feature
for iPad users by making it easier to research multiple destinations, and we
are delighted to help travelers who are just beginning the exploration
process." The Full Research Report on priceline.com Incorporated - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:

http://www.analystscorner.com/r/full_research_report/8186_PCLN

--

Alliance Data Systems Corporation Research Report 

On November 15, 2013, Alliance Data Systems Corporation (Alliance Data)
provided a performance update on its Private Label segment. Alliance Data
informed that average receivables of the Company during October 2013 stood at
$7.4 billion, up 14% YoY. Net charge-offs were $31.4 million or 5.1% as a
percentage of average receivables. The Company informed that in conjunction
with the release of its Master Trust Monthly Noteholder's Statement, Alliance
Data is also releasing similar metrics for the overall total managed
portfolio. The Full Research Report on Alliance Data Systems Corporation -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/bf7b_ADS

--

Cardtronics Inc. Research Report 

On November 4, 2013, Cardtronics Inc. (Cardtronics) reported its financial
results for Q3 2013. Total revenue increased 15.0% YoY to $228.8 million
during the quarter. Net loss attributable to controlling interests and
available to common stockholders was $8.4 million or $0.19 per diluted share
in Q3 2013, compared to net income attributable to controlling interests and
available to common stockholders of $12.9 million or $0.28 per diluted share
in Q3 2012. Cardtronics' CEO, Steve Rathgaber, commented, "We had another
strong quarter, which was highlighted by the completion of our largest
acquisition to date, which significantly expanded our European operations. We
were very pleased with the early returns from this investment, which was
included in our results for just under two months in the third quarter. Our
third quarter results also reflect our continued success in leveraging our
revenue growth into strong bottom line earnings growth, which was up 28% on an
adjusted per share basis." The Full Research Report on Cardtronics Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/6004_CATM

--

Verisk Analytics, Inc. Research Report 

On November 20, 2013, Verisk Analytics, Inc.'s subsidiary, Interthinx,
announced the release of its quarterly interactive Mortgage Fraud Risk Report,
covering data collected in Q3 2013. The Company informed that during Q3 2013,
the national Mortgage Fraud Risk Index valued at 108, indicating an increase
of 10% YoY. According to the Company, the quarterly findings of the report
also highlighted higher jumbo loan index values across all type-specific fraud
risks, with striking difference in the employment/income fraud risk index,
where the index value for jumbo loans stood at 146, against a value of 69 for
non-jumbo loans. "With the rise in popularity of jumbo loans, lenders must be
aware of both the credit risk and fraud risk those loans carry," said Ashley
Woodworth, Interthinx's Vice President of Business Development and Corporate
Strategy. "While the most significant fraud risk gap occurred in the area of
employment/income, it certainly wasn't the only area where risk was present.
Occupancy fraud risk for jumbos, for example, was extremely high - more than
200 by our index versus 150 for non-jumbo loans. The risk is out there, and
lenders need to be aware." The Full Research Report on Verisk Analytics, Inc.
- including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/54f1_VRSK

--

athenahealth, Inc. Research Report

On November 14, 2013, athenahealth, Inc.'s subsidiary, Epocrates, Inc.
(Epocrates), announced a partnership with The Cochrane Library to bring
selections of its internationally recognized evidence-based reviews,
editorials and meta-analyses to the Epocrates Rx application, further
informing the clinical choices made by health care providers. "This is a real
win for our million-plus clinician members," said Dr. Anne Meneghetti,
Executive Director of Medical Information for Epocrates. "Cochrane has earned
its place as a highly respected source by examining bodies of evidence in
specific areas, such as the accuracy of a diagnostic test for a specific
patient population. I believe it challenges common patterns of care and shines
a light on evidence behind commonly held practices, so clinicians can apply
optimal judgment in the moments of care." The Full Research Report on
athenahealth, Inc. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/501f_ATHN

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we
    are only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Namrata Maheshwari,
CFA, has only reviewed the information provided by Equity News Network in this
article or report according to the Procedures outlined by Equity News Network.
Equity News Network is not entitled to veto or interfere in the application of
such procedures by the outsourced provider to the articles, documents or
reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

AnalystsCorner.com

SOURCE Analysts' Corner

Contact: CONTACT PERSON: Joe Thomas CONTACT PHONE: +1-310-496-8071 (North
America)
 
Press spacebar to pause and continue. Press esc to stop.